Ann: Update on US FDA De Novo Classification Request, page-68

besides the fact you stole my picture , this is quite a possibility now. Management wouldn’t say NO to an exit chance now, let someone else deal with it type of mentality.

I understand the dump today, given they just did a CR too. However, we all know this is oversold. They still have regulatory approvals elsewhere, they still have sleep apnea, and better yet they can just reapply after the meeting and tweak the approval.